Related Experiment Video
Updated: Jul 9, 2026

07:53
Three-Dimensional Reconstruction for the Whole Lung with Early Multiple Pulmonary Nodules
Published on: October 13, 2023
Diffuse parenchymal lung diseases: 3D automated detection in MDCT.
Catalin Fetita1, Kuang-Che Chang-Chien, Pierre-Yves Brillet
1Dept. ARTEMIS, INT, Groupe des Ecoles des Télécommunications, Evry, France.
Summary
This study introduces a 3D automated method for diagnosing diffuse parenchymal lung diseases (DPLDs) like emphysema and fibrosis using MDCT scans. Promising results suggest potential for clinical use in evaluating new therapies.
Area of Science:
- Radiology
- Medical Imaging
- Pulmonary Medicine
Background:
- Accurate characterization of diffuse parenchymal lung disease (DPLD) severity is crucial for clinical research, especially for evaluating novel therapies.
- Current methods for quantifying DPLD, including interstitial lung diseases and emphysema, require robust automated approaches.
Purpose of the Study:
- To develop and validate a 3D automated approach for the detection and diagnosis of various DPLDs.
- To enable full characterization of parenchymal lung tissue using advanced image processing techniques.
Main Methods:
- A novel 3D automated methodology was developed, combining multi-resolution image decomposition via 3D morphological filtering.
- Graph-based classification was employed for comprehensive parenchymal tissue characterization.
- The approach targets the detection of emphysema, fibrosis, honeycombing, and ground glass opacities.
Main Results:
- The developed 3D automated approach demonstrated promising results in the detection and diagnosis of DPLDs.
- The methodology achieved a full characterization of parenchymal lung tissue.
Conclusions:
- The proposed 3D automated approach shows significant potential for clinical implementation and validation.
- This technique could facilitate routine clinical assessment and the evaluation of new therapeutic strategies for DPLDs.

